The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production

Molecular Immunology

Volumn 49, Issue 1-2, 2011, Pages 367-379

  Oldham, Athenia L ^a,b   Miner, Cathrine A ^a   Wang, Hong Cheng ^a   Webb, Carol F ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoantibodies; B lymphocyte; Bright transcription factor; Marginal zone development

Indexed keywords

AUTOANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRIGHT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL COUNT; CELL LINEAGE; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MARGINAL ZONE B LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL SEPARATION; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SPLEEN; TRANSCRIPTION FACTORS;

MUS MUSCULUS;

EID: 82455172017     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.09.008     Document Type: Article

References (70)

1. Allman D., Lindsley R.C., DeMuth W., Rudd K., Shinton S.A., Hardy R.R. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 2001, 167:6834-6840.
2. Allman D., Pillai S. Peripheral B cell subsets. Curr. Opin. Immunol. 2008, 20:149-157.
3. An G., Miner C.A., Nixon J.C., Kincade P.W., Bryant J., Tucker P.W., Webb C.F. Loss of Bright/ARID3a function promotes developmental plasticity. Stem Cells 2010, 28:1560-1567.
4. Andrews S.F., Rawlings D.J. Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription. J Immunol. 2009, 182:2868-2878.
5. Atencio S., Amano H., Izui S., Kotzin B.L. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J. Immunol. 2004, 172:4159-4166.
6. Ayoub N., Noma K., Isaac S., Kahan T., Grewal S.I., Cohen A. A novel jmjC domain protein modulates heterochromatization in fission yeast. Mol. Cell. Biol. 2003, 23:4356-4370.
7. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 2000, 192:1453-1466.
8. Bradshaw S., Zheng W.J., Tsoi L.C., Gilkeson G., Zhang X.K. A role for Fli-1 in B cell proliferation: Implications for SLE pathogenesis. Clin. Immunol. 2008, 129:19-30.
9. Bygrave A.E., Rose K.L., Cortes-Hernandez J., Warren J., Rigby R.J., Cook H.T., Walport M.J., Vyse T.J., Botto M. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2004, 2:E243.
10. Carey J.B., Moffatt-Blue C.S., Watson L.C., Gavin A.L., Feeney A.J. Repertoire-based selection into the marginal zone compartment during B cell development. J. Exp. Med. 2008, 205:2043-2052.
11. Carsetti R., Kohler G., Lamers M.C. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 1995, 181:2129-2140.
12. Cooney D.S., Phee H., Jacob A., Coggeshall K.M. Signal transduction by human-restricted Fc gamma RIIa involves three distinct cytoplasmic kinase families leading to phagocytosis. J. Immunol. 2001, 167:844-854.
13. Cyster J.G., Hartley S.B., Goodnow C.C. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 1994, 371:389-395.
14. DeKoter R.P., Geadah M., Khoosal S., Xu L.S., Thillainadesan G., Torchia J., Chin S.S., Garrett-Sinha L.A. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C. J. Immunol. 2010, 185:7374-7384.
15. Diamant E., Keren Z., Melamed D. CD19 regulates positive selection and maturation in B lymphopoiesis: lack of CD19 imposes developmental arrest of immature B cells and consequential stimulation of receptor editing. Blood 2005, 105:3247-3254.
16. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983, 11:1475-1489.
17. Fairhurst A.M., Wandstrat A.E., Wakeland E.K. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv. Immunol. 2006, 92:1-69.
18. Flach H., Rosenbaum M., Duchniewicz M., Kim S., Zhang S.L., Cahalan M.D., Mittler G., Grosschedl R. Mzb1 protein regulates calcium homeostasis, antibody secretion, and integrin activation in innate-like B cells. Immunity 2010, 33:723-735.
19. 2+ following B-cell receptor activation. EMBO J. 1998, 17:1973-1985.
20. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 1993, 177:999-1008.
21. Goodnow C.C., Crosbie J., Adelstein S., Lavoie T.B., Smith-Gill S.J., Brink R.A., Pritchard-Briscoe H., Wotherspoon J.S., Loblay R.H., Raphael K., Trent R.J., Basten A. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988, 334:676-682.
22. Hart G.T., Wang X., Hogquist K.A., Jameson S.C. Kruppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:716-721.
23. Hartley S.B., Cooke M.P., Fulcher D.A., Harris A.W., Cory S., Basten A., Goodnow C.C. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993, 72:325-335.
24. Herrscher R.F., Kaplan M.H., Lelsz D.L., Das C., Scheuermann R., Tucker P.W. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 1995, 9:3067-3082.
25. Johnston C.M., Wood A.L., Bolland D.J., Corcoran A.E. Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. J. Immunol. 2006, 176:4221-4234.
26. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., Davidson L., Muller S., Kantor A.B., Herzenberg L.A., Rosen F.S., Sideras P. Defective B cell development and function in Btk-deficient mice. Immunity 1995, 3:283-299.
27. Kin N.W., Crawford D.M., Liu J., Behrens T.W., Kearney J.F. DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. J. Immunol. 2008, 180:6663-6674.
28. Lai A., Kennedy B.K., Barbie D.A., Bertos N.R., Yang X.J., Theberge M.C., Tsai S.C., Seto E., Zhang Y., Kuzmichev A., Lane W.S., Reinberg D., Harlow E., Branton P.E. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol. Cell. Biol. 2001, 21:2918-2932.
29. Lamoureux J.L., Watson L.C., Cherrier M., Skog P., Nemazee D., Feeney A.J. Reduced receptor editing in lupus-prone MRL/lpr mice. J. Exp. Med. 2007, 204:2853-2864.
30. Lang J., Arnold B., Hammerling G., Harris A.W., Korsmeyer S., Russell D., Strasser A., Nemazee D. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J. Exp. Med. 1997, 186:1513-1522.
31. Lin D., Ippolito G.C., Zong R.T., Bryant J., Koslovsky J., Tucker P. Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer. Mol. Cancer 2007, 6:23.
32. Loder F., Mutschler B., Ray R.J., Paige C.J., Sideras P., Torres R., Lamers M.C., Carsetti R. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 1999, 190:75-89.
33. Loh C., Pau E., Chang N.H., Wither J.E. An intrinsic B-cell defect supports autoimmunity in New Zealand Black chromosome 13 congenic mice. Eur. J. Immunol. 2011, 41:527-536.
34. Maier S.M., Gross J.K., Hamlin K.L., Maier J.L., Workman J.L., Kim-Howard X.R., Schoeb T.R., Farris A.D. Proteinuria of nonautoimmune origin in wild-type FVB/NJ mice. Comp Med. 2007, 57:255-266.
35. Malhotra S., Kovats S., Zhang W., Coggeshall K.M. B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. J. Biol. Chem. 2009, 284:24088-24097.
36. Martin F., Kearney J.F. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a " natural immune memory" Immunol. Rev. 2000, 175:70-79.
37. Martin F., Kearney J.F. Marginal-zone B cells. Nat. Rev. Immunol. 2002, 2:323-335.
38. Merrell K.T., Benschop R.J., Gauld S.B., Aviszus K., Decote-Ricardo D., Wysocki L.J., Cambier J.C. Identification of anergic B cells within a wild-type repertoire. Immunity 2006, 25:953-962.
39. Nemazee D., Weigert M. Revising B cell receptors. J. Exp. Med. 2000, 191:1813-1817.
40. Nemazee D.A., Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989, 337:562-566.
41. Nijnik A., Ferry H., Lewis G., Rapsomaniki E., Leung J.C., Daser A., Lambe T., Goodnow C.C., Cornall R.J. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice. Int. Immunol. 2006, 18:1127-1137.
42. Nisitani S., Tsubata T., Murakami M., Okamoto M., Honjo T. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J. Exp. Med. 1993, 178:1247-1254.
43. Nixon J.C., Ferrell S., Miner C., Oldham A.L., Hochgeschwender U., Webb C.F. Transgenic mice expressing dominant-negative Bright exhibit defects in B1 B cells. J. Immunol. 2008, 181:6913-6922.
44. Nixon J.C., Rajaiya J., Webb C.F. Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation. J. Biol. Chem. 2004, 279:52465-52472.
45. Nixon J.C., Rajaiya J.B., Ayers N., Evetts S., Webb C.F. The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations. Cell. Immunol. 2004, 228:42-53.
46. O'Reilly L.A., Harris A.W., Tarlinton D.M., Corcoran L.M., Strasser A. Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J. Immunol. 1997, 159:2301-2311.
47. Okamoto M., Murakami M., Shimizu A., Ozaki S., Tsubata T., Kumagai S., Honjo T. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 1992, 175:71-79.
48. Oliver A.M., Martin F., Gartland G.L., Carter R.H., Kearney J.F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 1997, 27:2366-2374.
49. Oliver A.M., Martin F., Kearney J.F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 1999, 162:7198-7207.
50. Petro J.B., Gerstein R.M., Lowe J., Carter R.S., Shinners N., Khan W.N. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 2002, 277:48009-48019.
51. Pillai S., Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 2009, 9:767-777.
52. Rajaiya J., Hatfield M., Nixon J.C., Rawlings D.J., Webb C.F. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright. Mol. Cell. Biol. 2005, 25:2073-2084.
53. Rajaiya J., Nixon J.C., Ayers N., Desgranges Z.P., Roy A.L., Webb C.F. Induction of immunoglobulin heavy chain transcription through the transcription factor Bright requires TFII-I. Mol. Cell. Biol. 2006, 26:4758-4768.
54. Refaeli Y., Field K.A., Turner B.C., Trumpp A., Bishop J.M. The protooncogene MYC can break B cell tolerance. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4097-4102.
55. Roy V., Chang N.H., Cai Y., Bonventi G., Wither J. Aberrant IgM signaling promotes survival of transitional T1 B cells and prevents tolerance induction in lupus-prone New Zealand Black mice. J. Immunol. 2005, 175:7363-7371.
56. Satterthwaite A.B., Cheroutre H., Khan W.N., Sideras P., Witte O.N. Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13152-13157.
57. Shankar M., Nixon J.C., Maier S., Workman J., Farris A.D., Webb C.F. Anti-nuclear antibody production and autoimmunity in transgenic mice that over-express the transcription factor Bright. J. Immunol. 2007, 178:2996-3006.
58. Su T.T., Guo B., Wei B., Braun J., Rawlings D.J. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 2004, 197:161-178.
59. Su T.T., Rawlings D.J. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 2002, 168:2101-2110.
60. Teague B.N., Pan Y., Mudd P.A., Nakken B., Zhang Q., Szodoray P., Kim-Howard X., Wilson P.C., Farris A.D. Cutting edge: transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus. J. Immunol. 2007, 178:7511-7515.
61. Vidal S., Kono D.H., Theofilopoulos A.N. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J. Clin. Invest. 1998, 101:696-702.
62. Webb C.F. The transcription factor. Immunol. Res. 2001, 24:149-161.
63. Webb C.F., Bryant J., Popowski M., Allred L., Kim D., Harriss J., Schmidt C., Miner C.A., Rose K., Cheng H.L., Griffin C., Tucker P.W. The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development. Mol. Cell. Biol. 2011, 31:1041-1053.
64. Webb C.F., Das C., Coffman R.L., Tucker P.W. Induction of immunoglobulin μ mRNA in a B cell transfectant stimulated with interleukin-5 and a T-dependent antigen. J. Immunol. 1989, 143:3934-3939.
65. Webb C.F., Smith E.A., Medina K.L., Buchanan K.L., Smithson G., Dou S. Expression of Bright at two distinct stages of B lymphocyte development. J. Immunol. 1998, 160:4747-4754.
66. Webb C.F., Yamashita Y., Ayers N., Evetts S., Paulin Y., Conley M.E., Smith E.A. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 2000, 165:6956-6965.
67. Winkelmann R., Sandrock L., Porstner M., Roth E., Mathews M., Hobeika E., Reth M., Kahn M.L., Schuh W., Jack H.M. B cell homeostasis and plasma cell homing controlled by Kruppel-like factor 2. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:710-715.
68. Wu T., Qin X., Kurepa Z., Kumar K.R., Liu K., Kanta H., Zhou X.J., Satterthwaite A.B., Davis L.S., Mohan C. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J. Clin. Invest. 2007, 117:2186-2196.
69. Yamashita K., Sakamoto A., Ohkubo Y., Arima M., Hatano M., Kuroda Y., Tokuhisa T. c-fos Overexpression in splenic B cells augments development of marginal zone B cells. Mol. Immunol. 2005, 42:617-625.
70. Zeumer L., Sang A., Niu H., Morel L. Murine lupus susceptibility locus Sle2 activates DNA-reactive B cells through two sub-loci with distinct phenotypes. Genes Immun. 2011, 12:199-207.